VALIRX

valirx-logo

Valirx Plc, an investment holding company, engages in the research and development of oncology therapeutics and diagnostics in the United Kingdom. The company principally offers VAL 101 that acts to shut down the Bcl-2 gene, a proto-oncogene. It develops human papilloma virus diagnostic products based on the Nucleosomics, a platform for non-invasive tests for early cancer diagnosis based on epigenetic signal changes associated with malignancy; and HyperGenomics, a platform for differential diagnostic and prognostic tests in cancer, as well as testing for personalized medicine. The company also develops GeneICE compounds, which treat various diseases by acting to shut down harmful genes and prevent their expression. Valirx Plc is based in London, the United Kingdom.

#SimilarOrganizations #People #Financial #Event #Website #More

VALIRX

Industry:
Biotechnology Health Diagnostics Therapeutics

Founded:
2000-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.valirx.com

Total Employee:
1+

Status:
Active

Contact:
+44 (0)203 0084415

Email Addresses:
[email protected]

Total Funding:
1.22 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics


Similar Organizations

rare-partners-logo

Rare Partners

Rare Partners s.r.l. is a non profit company devoted to the development of new therapies and diagnostics in the field of rare diseases

Current Employees Featured

gerry-desler_image

Gerry Desler
Gerry Desler CFO @ ValiRX
CFO

cathy-tralau-stewart_image

Cathy Tralau-Stewart
Cathy Tralau-Stewart Chief Scientific Officer (Interim) @ ValiRX
Chief Scientific Officer (Interim)
2022-09-01

suzanne-dilly_image

Suzanne Dilly
Suzanne Dilly CEO @ ValiRX
CEO
2020-06-01

dr-satu-vainikka_image

Dr Satu Vainikka
Dr Satu Vainikka CEO @ ValiRX
CEO

not_available_image

Jake Micallef
Jake Micallef COO @ ValiRX
COO

not_available_image

Patrick J. Rousseau
Patrick J. Rousseau Chairman @ ValiRX
Chairman

dr-george-morris_image

Dr George Morris
Dr George Morris COO @ ValiRX
COO

Stock Details


Company's stock symbol is LSE:VAL

Acquisitions List

Date Company Article Price
2008-07-14 Chronos Therapeutics Chronos Therapeutics acquired by ValiRX N/A
2008-07-14 ValiPharma ValiPharma acquired by ValiRX N/A

Key Employee Changes

Date New article
2022-09-08 ValiRx Names Catherine Tralau-Stewart as Interim Chief Scientific Officer

Official Site Inspections

http://www.valirx.com Semrush global rank: 457.48 K Semrush visits lastest month: 113.7 K

  • Host name: 77.68.91.156
  • IP address: 77.68.91.156
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "ValiRX" on Search Engine